Dataset Information


Morniga-G, a T/Tn-Specific Lectin, Induces Leukemic Cell Death via Caspase and DR5 Receptor-Dependent Pathways.

ABSTRACT: Morniga-G, the Gal-specific black mulberry (Morus nigra) lectin, displays high affinity for T (CD176) and Tn (CD175) antigens, frequently expressed at the cancer cell surface. The effects of Morniga-G were investigated on a Tn-positive leukemic Jurkat cell line. The lectin, used in a concentration range between 5?20 ?g/mL, induced cell death in leukemic Jurkat cells. Microscopic and cytofluorometric analyses indicated that Jurkat cell death was essentially apoptotic, associated with an increase in the ceramide content and a depolarization of the mitochondrial transmembrane potential. This lectin-mediated cell death was inhibited by the pan caspase-inhibitor zVAD. In addition, cleavage of caspases 8, 9, and 3 was observed in Morniga-G-treated Jurkat cells whereas Jurkat cell lines that are deficient in caspase 8?10, caspase 9, or FADD, survived to the lectin-mediated toxicity. Furthermore, in the presence of TRAIL- or DR5-blocking mononoclonal antibodies, Jurkat cells became resistant to Morniga-G, suggesting that the lectin triggers cell death via the TRAIL/DR5 pathway. In silico computer simulations suggest that Morniga-G might facilitate both the DR5 dimerization and the building of TRAIL/DR5 complexes. Finally, upon treatment of Jurkat cells with benzyl-GalNAc, an O-glycosylation inhibitor, a decrease in Tn antigen expression associating with a reduced Morniga-G toxicity, was observed. Taken together, these results suggest that Morniga-G induces the cell death of Tn-positive leukemic cells via concomitant O-glycosylation-, caspase-, and TRAIL/DR5-dependent pathways.


PROVIDER: S-EPMC6337360 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3157357 | BioStudies
2007-08-31 | GSE8332 | GEO
2008-06-16 | E-GEOD-8332 | ArrayExpress
1000-01-01 | S-EPMC5323128 | BioStudies
2012-01-01 | S-EPMC3436762 | BioStudies
1000-01-01 | S-EPMC3887848 | BioStudies
2011-01-01 | S-EPMC3234758 | BioStudies
2019-01-01 | S-EPMC6536445 | BioStudies
1000-01-01 | S-EPMC3270986 | BioStudies
2013-01-01 | S-EPMC3593152 | BioStudies